Millennium Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.67M Sell
370,898
-248,054
-40% -$4.97M 0.01% 2610
2025
Q4
$14.5M Sell
618,952
-849,785
-58% -$18.4M 0.01% 1889
2025
Q3
$29.3M Buy
1,468,737
+874,706
+147% +$15.7M 0.02% 1286
2025
Q2
$8.14M Buy
594,031
+170,446
+40% +$1.64M 0.01% 2482
2025
Q1
$4.68M Sell
423,585
-222,200
-34% -$2.37M ﹤0.01% 2929
2024
Q4
$6.88M Sell
645,785
-853,416
-57% -$10.2M 0.01% 2521
2024
Q3
$19M Buy
1,499,201
+338,302
+29% +$5.02M 0.02% 1594
2024
Q2
$19.5M Buy
1,160,899
+1,119,019
+2,672% +$15.9M 0.02% 1519
2024
Q1
$628K Sell
41,880
-384,626
-90% -$6.29M ﹤0.01% 4655
2023
Q4
$6.4M Buy
426,506
+150,721
+55% +$1.96M 0.01% 2580
2023
Q3
$3.86M Buy
275,785
+83,657
+44% +$1.34M ﹤0.01% 2956
2023
Q2
$1.99M Sell
192,128
-162,648
-46% -$1.79M ﹤0.01% 3489
2023
Q1
$3.28M Buy
354,776
+77,528
+28% +$713K ﹤0.01% 2980
2022
Q4
$2.46M Sell
277,248
-162,274
-37% -$1.54M ﹤0.01% 3399
2022
Q3
$3.66M Sell
439,522
-176,723
-29% -$1.46M ﹤0.01% 3188
2022
Q2
$5.05M Buy
616,245
+459,341
+293% +$3.15M 0.01% 2798
2022
Q1
$1.37M Buy
156,904
+89,412
+132% +$697K ﹤0.01% 4231
2021
Q4
$642K Sell
67,492
-1,195
-2% -$16.8K ﹤0.01% 4827
2021
Q3
$1.16M Buy
68,687
+4,887
+8% +$77.5K ﹤0.01% 4519
2021
Q2
$974K Sell
63,800
-10,401
-14% -$188K ﹤0.01% 4694
2021
Q1
$1.45M Buy
74,201
+2,679
+4% +$56.9K ﹤0.01% 3840
2020
Q4
$1.29M Sell
71,522
-18,186
-20% -$381K ﹤0.01% 3564
2020
Q3
$1.73K Sell
89,708
-16,571
-16% -$375K ﹤0.01% 2709
2020
Q2
$2.78M Buy
+106,279
New +$2.6M 0.01% 2285
2019
Q4
Sell
-10,855
Closed -$258K 4672
2019
Q3
$258K Sell
10,855
-79,513
-88% -$2.6M ﹤0.01% 3644
2019
Q2
$3.25M Sell
90,368
-9,526
-10% -$351K 0.01% 2103
2019
Q1
$3.69M Sell
99,894
-9,998
-9% -$419K 0.01% 1974
2018
Q4
$4.73M Sell
109,892
-123,461
-53% -$5.55M 0.01% 1626
2018
Q3
$11M Buy
233,353
+61,021
+35% +$2.84M 0.02% 1246
2018
Q2
$8.57M Buy
172,332
+13,219
+8% +$769K 0.01% 1426
2018
Q1
$7.91M Buy
159,113
+147,628
+1,285% +$7.4M 0.01% 1504
2017
Q4
$427K Buy
+11,485
New +$409K ﹤0.01% 3175

Other funds holding URGN